Crinetics Pharmaceuticals Inc (CRNX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché CRNX Giù? Forum Previsione

Perché le azioni Crinetics Pharmaceuticals Inc (CRNX) sono in ribasso?

Abbiamo notato un calo di 5.92% nelle azioni di Crinetics Pharmaceuticals Inc (CRNX) durante la sessione di negoziazione di 2024-12-18. Sebbene ciò possa essere attribuito alla normale volatilità o a vari fattori interni ed esterni, tieni presente che stiamo monitorando attivamente la situazione e forniremo aggiornamenti tempestivi il prima possibile!

2023-09-13:

Crinetics Pharmaceuticals (CRNX) shares fell 6.70% after the company announced an offering of 11,441,648 common stock shares at $30.59 each, aiming to raise around $350 million before expenses. The offering includes an option for underwriters to buy an additional 1,716,247 shares. Funds will support research, development, and general corporate purposes, with J.P. Morgan, Morgan Stanley, Leerink Partners, Piper Sandler, and LifeSci Capital managing the offering.

https://www.globenewswire.com/news-release/2023/09/13/2742153/0/en/Crinetics-Pharmaceuticals-Announces-Pricing-of-Upsized-Public-Offering-of-Common-Stock.html

SMMT

$17.89

1.76%

GMAB

$20.77

1.19%

MRNA

$39.38

1.87%

UTHR

$357.64

0.64%

BGNE

$183.81

1.06%

BNTX

$112.58

1.20%

Crinetics Pharmaceuticals Inc (CRNX)

Perché le azioni Crinetics Pharmaceuticals Inc (CRNX) sono in ribasso?

Simile a CRNX